INTRODUCTION
demonstrated the presence of chondroitin sulfate N-acetylgalactosamine-6-sulfate sulfatase (6-sulfatase) ' in extracts of cultured human skin fibroblasts and have provided evidence that its deficiency is responsible for the pathogenesis of Morquio disease (mucopolysaccharidosis IV). For the assay, Matalon et al. (1) used biologically labeled polymeric chondroitin-4/6-sulfate extracted from femural and tibial epiphyses of chick embryos or oligosaccharides derived from it. The required purification of the substrate, the short half-life of the 35SO4 label, the need for electrophoretic separation of the released inorganic "5SO4 before its Dr. Tavella was on leave of absence from the Pediatric Institute, Universita Cattolica, Roma, Italy. Dr. Niebes' address is: Zyma, S. A., Nyon, Switzerland.
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measurement, and the need to ascertain whether the sulfate released was in position 4 or 6 of the galactosamine moieties make the method (1) rather laborious and not ideal for the routine assay of the enzyme activity. Using a 6-sulfated tetrasaccharide as a substrate, we have developed a simple method for the measurement of 6-sulfatase activity. This report describes the preparation of the substrate, the optimal conditions of the enzyme assay as established with a crude enzyme preparation from human kidney, and the applicability of the method for the diagnosis of Morquio disease. (9) , polymeric glycosaminoglycans are precipitated with cetylpyridinium chloride before addition of the gelatin-BaCl2 reagent.
METHODS
Substrate preparation. 400 mg of shark cartilage C-6-S dissolved in 8 ml of a pH 4.8, 0.125 M Tris-acetate buffer containing 1.6 ;Lmol of NaN3 were incubated at 370C with 12,000 USP units of testicular hyaluronidase for 48 h, and its depolymerization was monitored turbidimetrically (10) . Upon completion of incubation, the digest was boiled for 20 min to inactivate hyaluronidase and was clarified by centrifugation. The supernate, which is the substrate, was diluted with a pH 4.8, 0.125 M Tris-acetate buffer to give 32 ttmol hexuronate/ml, and stored frozen in portions until used. A portion of the degraded C-6-S was chromatographed on an AG 1 X 2 column (20 X 0.9 cm) packed with water and eluted with a linear gradient of 0-3.0 M NaCt in water (Fig. 1) . The molecular weight of the degraded C-6-S was determined by gel filtration (Fig. 2) on a BioGel A-0.5 m column (98 X 1 cm), packed and eluted with 0.025 M NaCl, as previously described (11) (12) (13) . The column was calibrated with various carbohydrates of known molecular weight (11) (Fig. 3 ) and its void volume was assessed with blue dextran 2000.
Enzyme preparation. Whole normal human kidney was homogenized at 50C in a Waring blendor (Waring Products Div., Dynamics Corp. of America, New Hartford, Conn.) with 1.2 ml of cold (50C) 0.15 M NaCl/g of wet tissue. After centrifugation at 600 g for 30 min at 0C, the supernate (50 ml) was dialyzed for 24 h at 50C against four changes of 0.15 M NaCl (1 liter each). The retentate was centrifuged at 20,200 g for 30 min at 0C and the supernate (which had 16.5 mg protein/ml [14] ) was stored frozen until used.
Human skin fibroblasts from normal individuals and from Morquio patients were cultured (11) and homogenized (15) as described previously. Urinary concentrates were prepared by precipitation of fresh urine with (NH)2SO4 at 70% saturation (11) . Leukocytes, harvested from whole blood according to Fallon et al. (16) , were homogenized by the same method used for fibroblasts. Before enzyme assay, all extracts and homogenates were dialyzed against 0.15 M NaCI, as described for the preparation of kidney extract.
Assay of kidney enzyme. Assays were performed in glass tubes (100 X 12 mm) prewashed in concentrated HNO3. The standard reaction mixture (total volume, 0.6 ml) contained: 0.3 ml of water containing 0.31 ,umol of NaN3, 0.15 ml of pH 4.8, 0.6 M Tris-acetate buffer, 0.05 ml of substrate solution (containing 1.6 ,umol of hexuronate), and 0.1 ml (1.65 mg protein) of kidney extract. Control tubes contained only the substrate or all of the other components minus substrate. After incubation at 37°C for 8 h, the released inorganic sulfate was measured as follows. To each tube (except for the one containing substrate alone) was added 1.6 ml of 4% trichloroacetic acid to precipitate proteins. At this time, the substrate control was mixed with the reaction components of the other control tube. The precipitate in each tube was removed by centrifugation at 685 g for 25 min at 5°C and the supernates were recovered. To a 1.4-ml portion of each supernate, 0.5 ml of gelatinBaCI2 reagent was added. After 15 min at room temperature, the turbidity produced was measured at 360 nm against water. Net absorbance values were obtained by subtracting the value of the control from that of corresponding complete reaction mixture. 1 unit of enzyme activity is defined as that amount releasing 1 nmol inorganic sulfate/ h at 37°C. Specific activity is units per milligram of protein.
Optimal conditions for the kidney enzyme (pH, length of incubation, amount of enzyme needed) and the effect upon it of various ions were determined with minor modifications of the described technique (see Figs. 4-7 and their legends).
Assay of fibroblast enzyme was performed under conditions given in the first paragraph of the preceding section but with an incubation period of 16 h. 0.1 ml of fibroblast extract usually had 0.4 mg protein. After The C-6-S used for the preparation of the substrate had a hexuronate/hexosamine/sulfate molar ratio of 1: 1: 1 (Table I) . Its molecular weight is reported (17) to be between 40,000 and 80,000 and it has a galactosamine-6-sulfate/galactosamine-4-sulfate molar ratio of 90/10 (17). When chromatographed on AG 1 x2, it was quantitatively eluted as a single peak with maximum at 1.7 M NaCl (Fig. 1) . From a Bio-Gel A-0.5 m column it eluted as a single peak with the void volume (Fig. 2) (Table I ). This material was eluted quantitatively from the AG 1X2 column (Fig. 1) as a broad peak, with maximum at 1.3 M NaCl. Analyses of the various fractions for sulfate or hexosamine revealed patterns of elution similar to that of hexuronate, thus excluding the presence of free hexuronate or free inorganic sulfate (Fig. 1) . Hyaluronidase-degraded C-6-S was eluted from Bio-Gel A-0.5 m column as a single peak (Fig. 2) and its molecular weight, as determined from the calibration shown in Fig. 3, was 980±8% . On the basis of its composition and molecular weight, the degraded C-6-S appears to be essentially a sulfated tetrasaccharide. In fact, its digestion with bovine liver ,8-glucuronidase produced free hexuronate (accounting for 50% of the hexuronate of the tetrasaccharide) and a trisaccharide (with mol wt=800+7%), containing hexuronate/hexosamine/sulfate in a molar ratio of 1: 2: 2.
With the 6-sulfated tetrasaccharide as substrate and human kidney extract as enzyme source, optimum conditions were established for 6-sulfatase measurement (Figs. 4-7) . Though the substrate contained equimolar levels of sulfate, hexosamine, and hexuronate, usually its concentration has been represented in terms of hexuronate. Since low levels of NaCl (< 0.05 M) (Fig. 7) augmented the enzyme activity, a NaCl concentration of 25 mM was always maintained in routine assays. Under these conditions the enzyme showed maximum activity at pH 4.8 (Fig. 4) . Enzyme activity was linear with time ( Fig. Sa) for 16 h, during which 41% of the sulfate present on the substrate was hydrolyzed; the deviation from linearity thereafter might be due to substrate depletion and/or inactivation of the enzyme. Essentially all of the sulfate present in the substrate was hydrolyzed by extended incubation, to suggest that with oligosaccharides the sulfatase might either hydrolyze "internal" sulfate or that it might continue to act after the concomitant action of P-N-acetylhexosaminidase and FIGURE 7 The effect of chloride and phosphate ions on the enzyme activity. Enzyme preparations previously dialyzed to remove chloride ions and progressive additions of NaCl to the reaction mixture were employed. Alternatively, a pH 4.8, 0.6 M sodium phosphate buffer was used to add increasing amount of phosphate ions to the reaction mixture. 9-glucuronidase present in the crude enzyme preparation. In view of the demonstration (1) that extracts of fibroblasts lacking /3-N-acetylhexosaminidase release as much 6-sulfate as extracts of normal fibroblasts from oligosaccharides (1) (the total amount being more than the sulfate present at the nonreducing terminus), it seems that, at least with low-molecular-weight substrates, the concomitant action of exoglycosidases might not be required. The kidney 6-sulfatase activity increased linearly with protein level (Fig. 5b) and the enzyme showed typical Michaelis-Menten kinetics (Fig.  6) , with an apparent Km of 2.5 mM. The concentration of the Tris-acetate buffer (pH 4.8) could be varied from 0.11 to 0.31 M without affecting the enzyme activity. Phosphate and high levels of NaCl (over 75 mM) inhibited the enzyme activity (Fig. 7) , which, however, was not affected by the addition to the incubation mixture of N-acetyl-n-galactosamine (< 1.6 /Amol), D-glucuronate (< 1.6 ,umol), inorganic sulfate (< 0.625 /Amol), polymeric C-6-S (< 1.6 utmol as hexuronate), or 4-sulfated tetrasaccharides (<1 Ihmol as galactosamine-4-sulfate). The latter ones were obtained from whale cartilage C-4-S by digestion with testicular hyaluronidase,2 according to the method given for preparing degraded C-6-S. The specific activity of the kidney 6-sulfatase, measured under standard assay conditions, was 24; and the precision of the methods, computed in terms of coefficient of variation, is ±6%. Its activity is totally destroyed by boiling for 30 min.
While the trisaccharide produced by digesting the tetrasaccharide (degraded C-6-S) with 9-glucuronidase is an equally good substrate, A-Di-6S or the polymeric C-6-S are not. These observations and the pH optimum of 4.8 show that the enzyme has properties different from those of the bacterial chondro-6-sulfatase (18) , which uses unsaturated 6-sulfated disaccharide as its substrate and shows maximum activity in an alkaline pH range.
DISCUSSION
The proposed assay of 6-sulfatase activity employs a natural substrate of simple preparation, which contains not more than 10% of galactosamine-4-sulfate. Since human kidney extract, as well as other crude enzyme preparations, contain 2 N-acetylgalactosamine-4-sulfate sulfatase (4-sulfatase or arylsulfatase B), some of the sulfate hydrolyzed from the substrate does not reflect the activity of 6-sulfatase. Although there are methods available (19, 20) for the removal of 4-sulfatase activity from enzyme preparation, its contribution may be measured by incubating a given enzyme preparation with the same amount of 4-sulfated tetrasaccharide present in the 6-sulfated tetrasaccharide substrate. By incubating the kidney extract with 0.16 Amol (as hexuronate) of 4-sulfated tetrasaccharides under the specified conditions, we have estimated that only 2.4% of the sulfate hydrolyzed may be due to the activity of 4-sulfatase on the 4-sulfated tetrasaccharides present in our substrate. The values reported in this paper have been corrected accordingly.
The suitability of the method for the diagnosis of Morquio disease from extracts of cultured skin fibroblasts is indicated by the data in Table II . The absence of measurable activity in Morquio fibroblasts is consistent with the finding of Matalon et al. (1) .
Concentrates of normal human urine and extracts of normal leukocytes were also assayed for 6-sulfatase with this method and the activities found were 37 and 47 units/mg protein, respectively.
